AngioDynamics (ANGO) Issues Preliminary Q3 Revenues, Revises Guidance for FY
Tweet Send to a Friend
AngioDynamics (NASDAQ: ANGO) expects fiscal third quarter 2008 net sales to grow approximately 14% from the year ago period to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
